Cargando…
Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Abnormal expression of serum TGF-β1 was found in patients with diabetic nephropathy. However, the association of TGF-β1 with the risk of diabetic nephropathy remains unknown. The present study was undertaken to investigate whether such an association exists. METHODS: We searched the Chin...
Autores principales: | Mou, Xin, Zhou, Di-Yi, Zhou, Dan-Yang, Ma, Jing-Ru, Liu, Ying-Hui, Chen, Hui-Ping, Hu, Yong-Bin, Shou, Cheng-Min, Chen, Jia-Wei, Liu, Wen-Hong, Ma, Guo-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764759/ https://www.ncbi.nlm.nih.gov/pubmed/26901047 http://dx.doi.org/10.1371/journal.pone.0149513 |
Ejemplares similares
-
A novel identified circular RNA, circ_0000491, aggravates the extracellular matrix of diabetic nephropathy glomerular mesangial cells through suppressing miR-101b by targeting TGFβRI
por: Mou, Xin, et al.
Publicado: (2020) -
Different Risk Indictors of Diabetic Nephropathy in Transforming Growth Factor-beta1 T869C CC/CT Genotype and TT Genotype
por: MOU, Xin, et al.
Publicado: (2016) -
Identification of potential therapeutic target genes in mouse mesangial cells associated with diabetic nephropathy using bioinformatics analysis
por: Mou, Xin, et al.
Publicado: (2019) -
TGF-Beta as a Master Regulator of Diabetic Nephropathy
por: Wang, Li, et al.
Publicado: (2021) -
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway
por: Wang, Dongdong, et al.
Publicado: (2018)